How To Set Up Pharma Manufacturing Unit In India – The Indian Pharmaceutical market is valued around USD $50billion as per recent studies , it includes both domestic consumption and exported value and it is believed to reach $120-130 billion by 2030,isn’t that inspiring ?
India is the 3rd largest Pharmaceutical producer by volume and 14th largest by value globally.It is known as the major producer of high quality , affordable generic medicines and supplier of vaccines.The Indian Pharmaceutical industry has been in demand over the past few years and according to the latest data, there could be an increase of 10% annually in the upcoming years.Â
India has become a hub for Foreign investement, the potential and support from the government by introducing the department of Biotechnology in 1986, under the ministry of Science and Technology,to promote the growth and manufacturing in this sector , as this sector lacks recognisation, funding and growth.Â
Table of Contents
ToggleAfter 2017, due to disputes with China , the decrease in dependency on China has been limited and the government has launched certain schemes to support and benefit domestic businesses. The Production Linked Incentive (PLI) Scheme was launched , Scheme for Promotion of Bulk Drug Parks (2020), Promotion of Medical Device Parks Scheme (2020), Pharmaceuticals Technology Upgradation Assistance Scheme (PTUAS) and many other .Â
The main motive of these schemes were to help domestic businesses and small sized firm to attain intensive growth and resulting in the establishment of many Pharamaceutical hubs in India. Overall Success Percentage of Indian Pharma Growth Schemes: ~72.5% , India has generated approximately 1.38 million jobs through pharmaceutical and associated government schemes by mid-2025.
Pharmaceutical units can be categorised broadly according to their Specialization and scale of operations . These different Pharmaceutical units meet the diverse demands of high quality Pharma Products . Some of them are mentioned below:Â
Third Party Pharma Manufacturing unit – This type of Pharmaceutical  unit produces medicine for other Pharma companies under their brand name. This model is in high demand due to cost-efficiency, faster production, and scalability.Â
Contract Pharma Manufacturing unit – It involves outsourcing the entire or partial production process to specialized manufacturers, it supports flexibility, reduces costs, and allows companies to focus on competencies and meeting the global drug demand effortlessly.Â
P2P Pharma Manufacturing or Loan Licensing System – (Principal-to-Principal) or loan licensing is where a firm gets its products manufactured by another under its license.
PCD Pharma System – (Propaganda cum Distribution ) Pharma system is a franchise based marketing model where companies provide product and marketing rights to distributors , this helps in increasing reach and sales simultaneously.Â
Bulk Drug (API) Manufacturing – It is known as the backbone of the Pharma industry and consists of various chemical synthesis , with high demand globally and reducing dependency on imports.
Herbal/Ayurvedic Drugs– they are obtained from natural sources and they are gaining popularity due to their zero or no side effects and work as natural remedies also due to high drug resistance. The western culture is adapting to this culture , that’s why their demand is very high in the market.
The Prefernces among investors towards different types of Pharamceutical unit varies and data has been showacased in that respect. There are many choices in the industries , which leaves the investors with a lot of options according to their needs and current demand for healthcare products.
INVESTOR INTEREST IN PHARMACEUTICAL UNITSÂ |
||||
PHARMA MODEL | INVESTOR’S PREFERENCE | KEY INVESTMENT DRIVERS | ||
Third Party Pharma Manufacturing | 25% | Low entry barrier, high scalability, reduced overhead | ||
Contract Pharma Manufacturing | 20% | End-to-end solutions, high-value clients, long-term partnerships | ||
P2P/Loan Licensing Manufacturing | 15% | Low capital requirement, fast market entry | ||
PCD Pharma System | 10% |
|
||
Bulk Drug (API) Manufacturing | 20% | High demand, export opportunities, government incentives | ||
Herbal/Ayurvedic Drugs Manufacturing | 10% | Growing global demand, natural product trend, less regulated markets |
Regulatory Approvals and licensesÂ
Key license required are:
Location and InfrastructureÂ
 It is one of the most important factors, selecting an industrial zone or Pharma park for    easy accessibility of raw materials, transportation network and other important requirements.
Investment and Capital
To start any business or unit , the key role is the investment or capital .
Machinery and EquipmentsÂ
Equipment establishment and validation , different types of machinery requirement , approvals for importing machinery and equipment . Documentation and custom regulations are necessary to be filled along with the need of skilled laborers.Â
Quality Assurance & Quality ControlÂ
Quality must be top most priority and it shouldn’t be taken lightly , implementing quality assurance and quality control at every stage of Supply Chain . Conduction of testing and regular inspection.Â
 Manpower and Technical Expertise
The minimum qualification of staff should be as per the guidelines released by D&C acts .Â
Staff Training and SOP development.Â
The roles designated : Quality & Control Assurance , Inspection , testing at every stage of supply management , regulatory and maintenance.Â
The consistent growth in the Pharmaceutical industry with an annual 10% increase , showcases that the future of Pharma in India is brighter than ever , with the government providing required funding and introducing several schemes highlighting the importance of this sector . The projected growth is to reach US$120-130 billion by 2030 helping the domestic businesses, small or big sized firms and leading Pharma companies around the country.
Â
Â
This will close in 0 seconds